3′-UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African Americans

Cancer Research

Volumn 72, Issue 6, 2012, Pages 1467-1477

  Zanetti, Krista A ^a,b   Haznadar, Majda ^a   Welsh, Judith A ^a   Robles, Ana I ^a   Ryan, Bríd M ^a   McClary, Andrew C ^a,c   Bowman, Elise D ^a   Goodman, Julie E ^d   Bernig, Toralf ^a,e   Chanock, Stephen J ^a   Harris, Curtis C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Division of Cancer Control and Population Sciences   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d GRADIENT   (United States)

^e MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE BINDING LECTIN 2; MICRORNA; MICRORNA 27A; UNCLASSIFIED DRUG; MANNOSE BINDING LECTIN; MBL2 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; AFRICAN AMERICAN; ALLELE; ARTICLE; BINDING AFFINITY; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; COLON CANCER; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MBL2 GENE; ONCOGENE; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE; AGED; BLOOD; COLON TUMOR; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; NEGRO; RISK; STATISTICS;

3' UNTRANSLATED REGIONS; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84858213550     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-3073     Document Type: Article

References (36)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-49.
2. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al., editors. SEER Cancer Statistics Review, 1975-2008 [Internet]. Bethesda, MD: National Cancer Institute; [updated 2011 Apr; cited 2011 Jun 30]; based on the Nov 2010 submission. Available from: http://seer.cancer.gov/.
3. Terzic J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology 2010;138:2101-14.
4. Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 1994;35:950-4.
5. Hansen S, Holmskov U. Structural aspects of collectins and receptors for collectins. Immunobiology 1998;199:165-89. (Pubitemid 28404340)
6. Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol 2003;40:423-9. (Pubitemid 37244035)
7. Presanis JS, Kojima M, Sim RB. Biochemistry and genetics of mannan-binding lectin (MBL). Biochem Soc Trans 2003;31:748-52. (Pubitemid 36981118)
8. Lee SG, Yum JS, Moon HM, Kim HJ, Yang YJ, Kim HL, et al. Analysis of mannose-binding lectin 2 (MBL2) genotype and the serum protein levels in the Korean population. Mol Immunol 2005;42:969-77. (Pubitemid 40489022)
9. Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol 1998;161:3169-75. (Pubitemid 28425746)
10. Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP, et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995;155:3013-20.
11. Petersen SV, Thiel S, Jensenius JC. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 2001;38:133-49. (Pubitemid 32786772)
12. Baccarelli A, Hou L, Chen J, Lissowska J, El Omar EM, Grillo P, et al. Mannose-binding lectin-2 genetic variation and stomach cancer risk. Int J Cancer 2006;119:1970-5. (Pubitemid 44356859)
13. Wang FY, Tahara T, Arisawa T, Shibata T, Yamashita H, Nakamura M, et al. Mannan-binding lectin (MBL) polymorphism and gastric cancer risk in Japanese population. Dig Dis Sci 2008;53:2904-8.
14. Olivo-Marston SE, Yang P, Mechanic LE, Bowman ED, Pine SR, Loffredo CA, et al. Childhood exposure to secondhand smoke and functional mannose binding lectin polymorphisms are associated with increased lung cancer risk. Cancer Epidemiol Biomarkers Prev 2009;18:3375-83.
15. Bernig T, Boersma BJ, Howe TM, Welch R, Yadavalli S, Staats B, et al. The mannose-binding lectin (MBL2) haplotype and breast cancer: an association study in African-American and Caucasian women. Carcinogenesis 2007;28:828-36. (Pubitemid 46523340)
16. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
17. Brodersen P, Voinnet O. Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Biol 2009;10:141-8.
18. Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 2010;10:389-402.
19. Goodman JE, Bowman ED, Chanock SJ, Alberg AJ, Harris CC. Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis 2004;25:2467-72. (Pubitemid 39625188)
20. variant GPS [Internet]. Bethesda, MD: National Cancer Institute; [cited 2011 Jun 30]. Available from: http://variantgps.nci.nih.gov/cgfseq/pages/snp500. do.
21. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5. (Pubitemid 40202029)
22. Stephens M, Scheet P. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet 2005;76:449-62. (Pubitemid 40250525)
23. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B (Methodological) 1995;57:289-300
24. National Center for Biotechnology Information [Internet]. Bethesda, MD: NIH; [cited 2011 Jun 30]. Available from: http://www.ncbi.nlm.nih.gov/projects/ SNP/.
25. Hiard S, Charlier C, Coppieters W, Georges M, Baurain D. Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebrates. Nucleic Acids Res 2010;38 (Database issue):D640-51.
26. Ziebarth JD, Bhattacharya A, Chen A, Cui Y. PolymiRTS Database 2.0: linking polymorphisms in microRNA target sites with human diseases and complex traits. Nucleic Acids Res 2012;40 (Database issue):D216-21.
27. Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency-revisited. Mol Immunol 2003;40:73-84.
28. Bernig T, Breunis W, Brouwer N, Hutchinson A, Welch R, Roos D, et al. An analysis of genetic variation across the MBL2 locus in Dutch Caucasians indicates that 30 haplotypes could modify circulating levels of mannose-binding lectin. Hum Genet 2005;118:404-15. (Pubitemid 43091211)
29. Nakagawa T, Kawasaki N, Ma Y, Uemura K, Kawasaki T. Antitumor activity of mannan-binding protein. Methods Enzymol 2003;363:26-33. (Pubitemid 37267661)
30. Nakagawa T, Ma BY, Uemura K, Oka S, Kawasaki N, Kawasaki T. Role of mannan-binding protein, MBP, in innate immunity. Anticancer Res 2003;23:4467-71. (Pubitemid 37474900)
31. Garred P, Larsen F, Seyfarth J, Fujita R, Madsen HO. Mannose-binding lectin and its genetic variants. Genes Immun 2006;7:85-94. (Pubitemid 43336050)
32. Ytting H, Christensen IJ, Jensenius JC, Thiel S, Nielsen HJ. Preoperative mannan-binding lectin pathway and prognosis in colorectal cancer. Cancer Immunol Immunother 2005;54:265-72. (Pubitemid 40174244)
33. Ytting H, Jensenius JC, Christensen IJ, Thiel S, Nielsen HJ. Increased activity of the mannan-binding lectin complement activation pathway in patients with colorectal cancer. Scand J Gastroenterol 2004;39:674-9. (Pubitemid 38916245)
34. O'Keefe SJ. Nutrition and colonic health: the critical role of the microbiota. Curr Opin Gastroenterol 2008;24:51-8. (Pubitemid 350190898)
35. Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, Liu S. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One 2010;5:e13735.
36. Heegaard NH, Schetter AJ, Welsh JA, Yoneda M, Bowman ED, Harris CC. Circulating microRNA expression profiles in early stage non-small cell lung cancer. Int J Cancer 2012;130:1378-86.